Uterine glands and their secretions are hypothesized to be essential for blastocyst implantation and decidualization in the uterus of rodents and humans. One factor solely expressed by uterine glands in mice is leukemia inhibitory factor (LIF), and Lif null mice are infertile because of defective blastocyst attachment to the uterine luminal epithelium (LE). Progesterone treatment of neonatal mice permanently ablates differentiation of uterine glands, resulting in an aglandular uterus in the adult. Progesterone-induced uterine gland knockout (PUGKO) mice were used to investigate the biological role of uterine glands in blastocyst implantation and stromal cell decidualization. As compared to controls, PUGKO mice cycled normally but were infertile. Histological assessment of PUGKO uteri on Days 5.5 and 8.5 postmating found a hatched blastocyst apposed to an intact LE without evidence of implantation or stromal cell decidualization. Expression of several implantation-related factors, including Lif and PTGS2, were altered in the PUGKO uterus, whereas expression of steroid hormone receptors and their regulated genes was not different. Artificial decidualization was observed in the uteri of control but not PUGKO mice. Further, intrauterine administration of LIF failed to promote artificial decidualization in the uterus of PUGKO mice. Thus, uterine glands and their secretions have important biological roles in blastocyst implantation and stromal cell decidualization in the uterus.
INTRODUCTION
In humans and rodents, implantation involves blastocyst apposition, attachment, and adhesion to the luminal epithelium (LE) followed by penetration and growth of the trophectoderm into the decidualized stroma [1] . This complex process requires a dialogue between an implantation-competent blastocyst and a receptive uterus [1] . In mice, the endometrium becomes receptive to blastocyst implantation on Day 3.5 of pregnancy or pseudopregnancy, but it is nonreceptive by the afternoon of Day 4.5 [2] . The implantation process is initiated by blastocyst attachment to the LE that occurs at midnight on Gestational Day (GD) 3.5. By GD 5.5, the LE cells at the implantation sites undergo apoptosis, allowing the motile blastocyst trophectoderm to come into contact with stromal cells that are differentiating into decidual cells [3, 4] . Decidualization is required for successful pregnancy and is important for implantation of the blastocysts and formation of a functional placenta [1, 5] .
Endometrial function is regulated by the ovarian steroid hormones estrogen and progesterone [6, 7] . Under the influence of those steroids, the LE, glandular epithelia (GE), and stroma express genes important for blastocyst implantation [8] , including cytokines, growth factors, and lipid mediators [2, 9] . Secretions present in the uterine lumen of mice are not well characterized but are likely derived primarily from GE and comprised of amino acids, glucose, lipids, ions, proteins, and other substances based on studies in humans and domestic animals [10] [11] [12] [13] . Research using the uterine gland knockout (UGKO) sheep model emphasized the importance of GE and their secretions for conceptus survival and implantation [14, 15] . In humans, deficient glandular activity during the secretory phase of menstrual cycle has been correlated with unexplained infertility [16, 17] . In mice, leukemia inhibitory factor (LIF) is expressed solely by the GE, produced in response to nidatory estrogen from the ovary on Day 3.5 postmating, and is essential for blastocyst attachment to the LE and perhaps stromal cell decidualization [18] [19] [20] . However, the precise role of uterine glands in blastocyst implantation and decidualization has not been defined.
Acute exposure of neonatal mice to progesterone from Postnatal Day 2 (P2, where P0 ¼ birth) to P10 permanently ablates differentiation of uterine glands that normally occurs during the second and third weeks of life [21, 22] . The resulting adult mice cycle normally but are infertile [22] . Here, we used the progesterone-induced uterine gland knockout (PUGKO) mouse model to test the hypothesis that uterine glands and their secretions have an important biological role in blastocyst implantation and stromal cell decidualization in the uterus.
MATERIALS AND METHODS

Animals and Hormonal Treatments
All the animal procedures were approved by the Institutional Animal Care and Use Committee and conducted according to the institutional guidelines for the care and use of laboratory animals. As described previously [21] , female C57BL/6J pups were randomly assigned to treatment groups on P2 and received daily subcutaneous (s.c.) injections to P10 with sesame oil vehicle alone (Sigma-Aldrich) as a control or progesterone (P4) at 50 lg/g body weight in sesame oil to inhibit uterine gland development and produce the PUGKO phenotype.
To study pregnancy or pseudopregnancy, 8-wk-old female control and PUGKO mice were mated with fertile or vasectomized males with the day of the postcoital vaginal plug designated as GD 0.5 or day of pseudopregnancy 0.5 (DOPP 0.5), respectively. Implantation sites were visualized on GD 5.5 and 8.5 by intravenous injection of 1% Evans blue dye (Sigma-Aldrich) into the tail vein 5 min before necropsy. At the time of necropsy, uterine tissues were fixed in 4% paraformaldehyde in PBS (pH 7.2) overnight for histology or snap frozen in liquid nitrogen and stored at À808C for RNA extraction.
Artificial decidualization experiments were conducted as described previously [23] except that sesame oil was used as the decidual stimulus. Six-week-old female control and PUGKO mice were bilaterally ovariectomized. After a 2-wk rest period, mice were treated with 3 daily s.c. injections of 100 ng of 17b-estradiol (E2; Sigma-Aldrich) in sesame oil. After 2 days of rest, the mice received daily s.c. injections of 1 mg P4 plus 6.7 ng of E2 in sesame oil for 3 days. At 6 h after the last P4 plus E2 injection, 50 ll of sesame oil was administered into the lumen of the right uterine horn as a decidual stimulus. Injections of P4 (1 mg) with E2 (6.7 ng) were continued for 5 days before necropsy to study the decidual response. At necropsy, the uterus was removed and photographed, and then each uterine horn was weighed separately.
In order to determine if LIF could rescue the decidualization defect in PUGKO mice, 6-wk-old female control and PUGKO mice were bilaterally ovariectomized and allowed to rest for 2 wk. All the mice received daily s.c. injections of 100 ng E2 for 3 days. After a 2-day rest, the mice were treated with s.c. injections of 1 mg P4 for 6 days. Six hours after the second P4 injection, mice received injections of 10 ll of 10% BSA into the left uterine horn or 10 ll of recombinant human LIF (100 ng/ll in 10% BSA; LIF1005; Millipore) into the lumen of the right uterine horn. Six hours after the third daily P4 injection, 50 ll of sesame oil was administered into the lumen of each uterine horn as a decidual stimulus. After 3 days, the uterus was removed and photographed, and then each uterine horn was weighed separately.
RNA Isolation and Quantitative Real-Time RT-PCR Analysis
Gene expression analysis via quantitative real-time RT-PCR was conducted using methods previously described by our laboratory [24] . Briefly, total RNA was isolated from uterine samples using TRIzol reagent (Invitrogen) according to manufacturer's recommendations. Total RNA was digested with DNase I followed by cleanup using Qiagen RNeasy MinElute (Qiagen). Total RNA (1 lg) was reverse transcribed using oligo dT primer (Promega) and SuperScript II Reverse Transcriptase (Invitrogen). Control reactions in the absence of reverse transcriptase were prepared for each sample to test for genomic DNA contamination. Real-time PCR analysis was performed using CFX Connect Real-time PCR Detection System (Bio-Rad Laboratories) and SsoAdvanced SYBR Green Supermix (Bio-Rad) and using specific oligonucleotide primers designed by Oligo 7 program (Molecular Biology Insights, Inc.). Mouse Rpl13a was used as a reference gene; all the primer information is presented in Supplemental Table S1 (all the Supplemental Data are available online at www. biolreprod.org).
Immunohistochemistry
Uteri were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 5 lm. Sections were mounted on slides, deparaffinized, and rehydrated in a graded alcohol series. Uterine sections were subjected to antigen retrieval by boiling in 10 mM citrate buffer (pH 6.0) for 10 min, preincubated in 10% normal goat serum in PBS (pH 7.5) for 10 min at room temperature, and then incubated overnight in primary antibody at 48C. The following primary antibodies, diluted in 1% BSA in PBS (pH 7.5), were used: anti-ESR1 at 0.8 lg/ml (sc-542; Santa Cruz Biotechnology); anti-FOXA2 at 1.2 lg/ml (LS-C 138006; LifeSpan Biosciences); anti-PGR at 1 lg/ml (A0098; Dako); and anti-PTGS2 at 2 lg/ml (160106; Cayman Chemicals). Negative controls were conducted by substituting the primary antibody with normal immunoglobulin G (Sigma-Aldrich) at the same final concentration. Sections were washed in PBS and incubated with biotinylated secondary antibody at 5 lg/ml (PK-4001; Vector Laboratories) followed by immunoreactive protein visualization using a Vectastain ABC kit (Vector Laboratories) and diaminobenzidine tetrahydrochloride (Sigma-Aldrich) as the chromagen. The sections were counterstained with hematoxylin before affixing the coverslips.
Statistical Analyses
All the quantitative data were subjected to least-squares analyses of variance (ANOVA) using the general linear models' procedures of the Statistical Analysis System (SAS Institute Inc.). For analysis of real-time PCR data, the Ct values of the target mRNA were analyzed for effects of day, treatment (control or PUGKO), and their interaction (day 3 treatment) with the Rpl13a value used as a covariate. In all the analyses, error terms used in tests of significance were identified according to the expectation of the mean squares for error. Significance (P , 0.05) was determined by probability differences of least-squares means. Uterine weight data are presented as least-squares means with standard error. Real-time PCR data are presented as fold change relative to the mRNA level in uteri from the control mice.
RESULTS
Neonatal Progesterone Administration Inhibits Endometrial Gland Differentiation in the Mouse Uterus
Acute exposure of neonatal C57/BL6J female mice to progesterone from P2 to P10 ablated endometrial gland differentiation, resulting in a PUGKO phenotype in the adult (Fig. 1A) . The uteri of adult PUGKO females did not contain GE but did contain histologically normal LE, stroma, and myometrium when compared to control mice (Fig. 1A) . Forkhead box A2 (FOXA2) protein was evaluated because it is expressed uniquely in the uterine glands of mice [25] . In control mice on DOPP 2.5 ( Fig. 1A) , FOXA2 protein was detected solely in the nuclei of GE cells in the uterus, whereas the PUGKO uterus lacked detectable FOXA2 protein due to the absence of GE in the uterus. Consequently, the relative levels of Foxa2 mRNA were considerably higher (day 3 treatment, P , 0.01) in the uteri of pseudopregnant control as compared to PUGKO mice (Fig. 1B) . As noted previously [25] , Foxa2 mRNA declined (day, P , 0.01) between DOPP 2.5 and 4.5 in the uteri of control mice. The low levels of Foxa2 mRNA detected in uteri of PUGKO mice by real-time PCR is likely due to FOXA2-positive immune cells that are present predominantly in the outer circular layer of the myometrium (data not shown). The expression of serine peptidase inhibitor, Kazal type 3 (Spink3) was determined because it is also expressed exclusively in the uterine glands of the mouse uterus [26] . As illustrated in Figure 1B , Spink3 mRNA increased substantially (day 3 treatment, P , 0.01) in the uteri of control but not PUGKO mice between DOPP 2.5 and 4.5.
Embryo Implantation Is Impaired in PUGKO Mice
As observed in control mice, PUGKO mice also displayed regular estrous cycles and normal mating behavior indicated by the presence of copulatory plugs in the vagina following mating to an intact or vasectomized male. In contrast to control mice, PUGKO mice exhibited complete infertility when bred with intact males (data not shown).
A series of experiments were performed to determine the nature of the fertility defect in PUGKO mice. First, control and PUGKO mice were mated to intact males, and the uterus was gently flushed to recover blastocysts on GD 3.5. As illustrated in Figure 2A , blastocysts of normal morphology were recovered from the uteri of control and PUGKO mice. Further, equal numbers of blastocysts were recovered from the uteri of control and PUGKO mice on GD 3.5 (Fig. 2B) . Next, control and PUGKO mice were mated to intact males, and the number of implantation sites assessed during early pregnancy by intravenous injection of macromolecular blue dye [27] . As shown in Figure 3A , implantation sites were easily discernible on GD 5.5 and 8.5 in the uteri of control but not PUGKO mice; note the accumulation of blue dye at the implantation sites in the uterine horns of control mice. Uteri were then sectioned longitudinally in order to evaluate the implantation sites (Fig.  3B) . The uteri of GD 5.5 and 8.5 control mice contained implanted blastocysts surrounded by decidualizing stroma. In contrast, the blastocysts were not implanted into the endometrium of the uterus in PUGKO mice. The blastocysts were in apposition to an intact LE with underlying stroma that lacked morphological signs of transformation to polyploid decidual cells.
In mice, PTGS2 is expressed in the LE and the underlying decidualizing stroma at the site of blastocyst attachment [28] . Indeed, PTGS2-derived prostaglandins are essential for blastocyst implantation and decidualization [1] . In the uteri of control mice on GD 4.5, PTGS2 was present predominantly in the decidualizing stroma and in the LE at the site of blastocyst attachment (Fig. 3C) . In contrast, PTGS2 was abundant in LE and absent in the stroma adjacent to the embryo in uteri of PUGKO mice, which is consistent with the lack of morpho- 
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logically distinct polyploidy decidual cells in the uteri of PUGKO mice.
Steroid Hormone Receptor and Endometrial Receptivity Expression
Successful implantation requires an interaction between an implantation-competent blastocyst and a receptive endometrium, which is coordinately regulated by ovarian hormones estrogen and progesterone that exert their function via cognate receptors expressed in the uterus [1, 29] . As illustrated in Figure 4A , immunoreactive PGR protein was present predominantly in the nuclei of uterine epithelia on DOPP 2.5 and 3.5 and then increased in the stroma on DOPP 4.5. Immunoreactive ESR1 protein was abundant in the endometrial glands of uteri from pseudopregnant control mice and also observed in the LE and stroma (Fig. 5A) . Of note, spatiotemporal patterns of PGR and ESR1 were comparable and not different in uteri of pseudopregnant control and PUGKO mice. Figures 4B and 5B, expression of Pgr and progesterone-regulated genes (Hand2, Hoxa10, Il13ra2) as well as Esr1 and estrogen-regulated genes (Igf1, Muc1) were not different (day 3 treatment, P . 0.10) in the uteri of pseudopregnant control and PUGKO mice. In contrast, expression of Lif increased between DOPP 2.5 and 3.5 in the uteri of control mice (Fig. 5B) but not in the uterus of PUGKO mice (day 3 treatment, P , 0.01), which is consistent with the absence of uterine GE.
As shown in
A number of genes, expressed in the LE and GE of the mouse uterus during early pregnancy, mediate hormone responses and govern blastocyst implantation [1, 2, 8, [30] [31] [32] . As illustrated in Supplemental Figure S1 , real-time PCR analyses found that Hegf1, Ihh, Msx2, Nog, Ptgs2, Sfrp4, Wnt4, and Wnt7a mRNA levels were not different (day 3 treatment, P . 0.10) in the uteri of pseudopregnant control and PUGKO mice. Only Msx1 was higher on DOPP 4.5 in uteri of PUGKO as compared to control mice but not on DOPP 2.5 and 3.5 (day 3 treatment, P ¼ 0.02). 
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Decidualization Is Compromised in the PUGKO Uterus
To determine the role of endometrial glands in decidualization, an experiment was conducted to assess the ability of the uterus of control and PUGKO mice to artificially decidualize (Fig. 6A) . The uterus of control mice displayed a robust decidual response (Fig. 6B) , as noted by the increased size and wet weight of the stimulated (right) horn compared (P , 0.01) to the unstimulated (left) horn. In contrast, the uterus of PUGKO mice failed to decidualize, as the size or wet weight of the stimulated (right) horn was not different (P . 0.10) from that of the unstimulated (left) uterine horn.
Implantation and decidualization defects are observed in Lif null mice [19] , and Chen and coworkers [33] reported that LIF can substitute for the nidatory estrogen surge from the ovary in terms of inducing blastocyst implantation with subsequent decidualization in ovariectomized, progesterone-treated mice. Thus, control and PUGKO uteri were assessed for their ability to undergo the artificially induced decidual response when nidatory estrogen was replaced with an intrauterine injection of recombinant LIF (Fig. 7A) . The size and wet weight of the uterine horn in control mice receiving the decidual oil stimulus and LIF (right) was greater (P , 0.01) than the uterine horn (left) receiving the decidual stimulus alone (Fig. 7, B and C) . In contrast, no increase in size or wet weight of the uterine horn was observed (P . 0.10) in PUGKO mice.
DISCUSSION
This study confirms that acute exposure of neonatal mice to progesterone can be used as an easy and effective tool to inhibit postnatal endometrial adenogenesis, resulting in adult mice that have aglandular uteri as recently reported by our laboratory and others [21, 22] . A recent study found that conditional ablation of Foxa2 in the postnatal mouse uterus using the PGR-Cre mouse model resulted in a reduction and near absence of endometrial glands in the adult, indicating that FOXA2 is a critical regulator of endometrial adenogenesis in the mouse uterus [25] . In the lung and prostate, FOXA2 also regulates epithelial budding and morphogenesis [34, 35] . In agreement with our recent study [21] , the present study found that FOXA2 is a sensitive marker of GE differentiation and development because Foxa2 expression was detected in control but not PUGKO adult mice that histologically lack uterine glands. The nuclear localization of FOXA2 in the GE cells is similar to other reports that Foxa2 is predominantly expressed by GE cells [21, 24, 25] and is consistent with its function as a transcription factor regulating epithelial organogenesis [36] .
In humans and rodents, uterine glands and their secretions have been hypothesized to play important roles in blastocyst implantation and decidualization in the uterus [13, 19, 37, 38] . The present results with the aglandular PUGKO mouse model, along with those from conditional Foxa2 mutant mice that have ENDOMETRIAL GLANDS AND UTERINE FUNCTION much reduced uterine glands [25] and Lif null mice [19] , strongly supports the hypothesis that uterine glands and, by inference, their secretions have important biological roles governing blastocyst implantation and stromal cell decidualization, which are required for successful pregnancy in both mice and humans [2, 16] . The present study found that the major histological defect in the PUGKO mouse was the absence of GE in the uterus. No other morphological or functional defects were observed in PUGKO mice. Unimplanted and morphologically normal blastocysts were recovered from the PUGKO uterus on GD 3.5, suggesting normal function of the pituitary, ovary, oviduct, and vagina. Further, spatiotemporal patterns of steroid receptor expression and steroid hormone-regulated genes were not altered in the uterus of pseudopregnant PUGKO mice. Therefore, the lack of uterine glands appears to be the key defect that underlies the infertility and lack of blastocyst implantation in the uterus of PUGKO mice. Similarly, the reduced endometrial glands in Foxa2 conditional mutant mice [25] and their absence in UGKO ewes [14] results in severe subfertility or infertility, respectively, that manifests in a lack of blastocyst implantation. Importantly, delayed embryo implantation was not observed in PUGKO uteri. Thus, the defect in blastocyst implantation in PUGKO mice is likely due to inadequate uterine receptivity and/or trophectoderm attachment and motility that are critical processes in blastocyst implantation [1, 7, 32, 39] .
Several signaling pathways necessary for implantation have been identified in mice [2, 31, 40] . Of particular note, Lif null mice exhibit defects in blastocyst implantation [19] . In mice, LIF is induced in the uterine glands in response to the surge of nidatory estrogen on the morning of implantation [33, 41] and is also expressed in the subluminal stroma at the implantation site [42] . LIF is critical for embryo implantation [19, 41] and has pleiotropic effects on both uterine epithelium and stroma [33, 43] . In the present study, Lif was considerably reduced in the pseudopregnant PUGKO uterus and did not exhibit the induction observed in control mice on DOPP 3.5. The absence of uterine glands and their essential secreted factors, including LIF and other factors such as SPINK3 [19, 26] , is hypothesized to underlie the blastocyst implantation failure observed in the uteri of PUGKO mice. Importantly, the PUGKO model should be useful to identify uterine gland-specific factors important for blastocyst implantation.
In addition to defects in blastocyst implantation, the uterus of PUGKO mice also possessed a defect in stromal cell decidualization after mating or artificial hormone induction. The lack of stromal cell decidualization was initially observed on Day 4.5 postmating, as the normal expression of PTGS2 in stroma underneath the implanting blastocyst was not observed FILANT AND SPENCER in PUGKO uteri. The enzyme PTGS2 is involved in prostaglandin synthesis and is expressed in LE and stromal cells around the implanting blastocyst during the attachment reaction [28] , and Ptgs2 null mice display defects in both implantation and decidualization [44] . In the present study, PUGKO mice exhibited persistent PTGS2 expression in the LE that was absent in the stroma on day 4.5 postmating, which is similar to findings in Lif null mice [42] . Further, the uterus of Foxa2 conditional mutant mice, with much reduced endometrial glands, and Lif null mice also exhibit a severe stromal cell decidualization defect revealed by artificial hormone induction [25, 33] . Of note, LIF can replace nidatory estrogen at inducing both implantation and decidualization in hormonally prepared ovariectomized bred mice that contain endometrial glands [33] . However, intraluminal LIF only partially rescued the impaired deciduogenic response in conditional Foxa2 mutant mice using an artificial hormone induction regimen [25] . In the present study, intrauterine injections of LIF into the lumen of aglandular PUGKO mice failed to rescue any decidualization in an artificial hormone induction experiment. The decidual response observed in the uterine horn of control mice injected with recombinant LIF validated the experimental design and approach. Thus, available evidence supports the idea that the uterine glands secrete other unidentified factors in addition to LIF that govern stromal cell decidualization. Although Spink3 mRNA is expressed only in the endometrial GE of the mouse uterus, SPINK3 protein is present in the LE and decidual cells as well as uterine glands [26] . That finding suggests that SPINK3 is secreted in both an apical and basal manner, as found for many other proteins secreted by polarized epithelia [45] . Further, the LE and presumably factors it secretes upon LIF stimulation also has a role in uterine decidualization [46] . Thus, paracrine crosstalk between the GE and stroma, LE and stroma, as well as exocrine crosstalk between the GE and LE and perhaps GE and trophectoderm may be necessary for successful uterine decidualization. The PUGKO mouse model may be very useful to discover the cellular factors involved in stromal cell decidualization.
In summary, the present studies using the PUGKO mouse model strongly support the hypothesis that uterine glands and their secretions have an important biological role in blastocyst implantation and stromal cell decidualization in the uterus. The precise nature of secretions in the uterine luminal fluid of mice is particularly not well understood. Interrogation of the endometrial epithelial transcriptome and secretome of early pregnancy using discovery-based systems biology approaches in combination with PUGKO mice should be useful to elucidate critical factors governing the acquisition of endometrial receptivity and trophectoderm attachment and motility that are required for blastocyst implantation as well as for stromal cell decidualization [8, 32] . 
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